BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17373113)

  • 1. [Detection of free light chains--a new method of diagnostics of haematological diseases].
    Mecl J; Benáková H; Nohejlová A; Straub J; Zima T; Spicka I
    Cas Lek Cesk; 2007; 146(2):159-62. PubMed ID: 17373113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
    Wolff F; Thiry C; Willems D
    Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving use of serum free light chain assays in haematology.
    Pratt G
    Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
    Nowrousian MR; Brandhorst D; Sammet C; Kellert M; Daniels R; Schuett P; Poser M; Mueller S; Ebeling P; Welt A; Bradwell AR; Buttkereit U; Opalka B; Flasshove M; Moritz T; Seeber S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8706-14. PubMed ID: 16361557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest and limit of a free light chain immunoassay in serum and urine for the diagnosis and the follow-up of monoclonal dysglobulinemia].
    Lopez J; Dauwalder O; Joly P; Dimet I; Bienvenu J; Bernon H
    Ann Biol Clin (Paris); 2006; 64(3):287-97. PubMed ID: 16698567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.
    Abraham RS; Katzmann JA; Clark RJ; Bradwell AR; Kyle RA; Gertz MA
    Am J Clin Pathol; 2003 Feb; 119(2):274-8. PubMed ID: 12579999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
    Tate JR; Mollee P; Dimeski G; Carter AC; Gill D
    Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.
    Martin W; Abraham R; Shanafelt T; Clark RJ; Bone N; Geyer SM; Katzmann JA; Bradwell A; Kay NE; Witzig TE
    Transl Res; 2007 Apr; 149(4):231-5. PubMed ID: 17383597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum free light chains for monitoring multiple myeloma.
    Mead GP; Carr-Smith HD; Drayson MT; Morgan GJ; Child JA; Bradwell AR
    Br J Haematol; 2004 Aug; 126(3):348-54. PubMed ID: 15257706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the Sebia CAPILLARYS 2 for detection and immunotyping of serum monoclonal paraproteins.
    Yang Z; Harrison K; Park YA; Chaffin CH; Thigpen B; Easley PL; Smith JA; Robinson CA; Lorenz RG; Hardy RW
    Am J Clin Pathol; 2007 Aug; 128(2):293-9. PubMed ID: 17638665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
    Abadie JM; Bankson DD
    Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory identification of monoclonal immunoglobin].
    Tichý M; Maisnar V
    Vnitr Lek; 2006 Nov; 52 Suppl 2():41-5. PubMed ID: 18181283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.
    Bochtler T; Hegenbart U; Heiss C; Benner A; Cremer F; Volkmann M; Ludwig J; Perz JB; Ho AD; Goldschmidt H; Schonland SO
    Haematologica; 2008 Mar; 93(3):459-62. PubMed ID: 18287137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new concept for detection of Bence Jones proteinuria in patients with monoclonal gammopathy.
    Hofmann W; Garbrecht M; Bradwell AR; Guder WG
    Clin Lab; 2004; 50(3-4):181-5. PubMed ID: 15074473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins.
    Bakshi NA; Gulbranson R; Garstka D; Bradwell AR; Keren DF
    Am J Clin Pathol; 2005 Aug; 124(2):214-8. PubMed ID: 16040291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.